Browse by UCL people
Group by: Type | Date
Jump to: Article
Number of items: 29.
Article
Backen, AC;
Lopes, A;
Wasan, H;
Palmer, DH;
Duggan, M;
Cunningham, D;
Anthoney, A;
... Valle, JW; + view all
(2018)
Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial.
British Journal of Cancer
, 119
pp. 27-35.
10.1038/s41416-018-0132-8.
|
 |
|
Biasco, L;
Izotova, N;
Rivat, C;
Ghorashian, S;
Richardson, R;
Guvenel, A;
Hough, R;
... Amrolia, PJ; + view all
(2021)
Clonal expansion of T memory stem cells determines early anti-leukemic responses and long-term CAR T cell persistence in patients.
Nature Cancer
, 2
pp. 629-64.
10.1038/s43018-021-00207-7.
|
|
Bray, T;
Sakai, N;
Dudek, A;
Fisher, C;
Rajesparan, K;
Lopes, A;
Ciurtin, C;
... Hall-Craggs, M; + view all
(2020)
Histographic Analysis of Oedema and Fat in Inflamed Bone Marrow based on Quantitative MRI.
European Radiology
, 313
10.1007/s00330-020-06785-x.
|
|
|
Bray, TJP;
Lopes, A;
Fisher, C;
Ciurtin, C;
Sen, D;
Hall-Craggs, MA;
(2019)
Sacroiliac Joint Ankylosis In Young Spondyloarthritis Patients Receiving Biologic Therapy: Observation of Serial MRI scans.
Arthritis and Rheumatology
, 71
(4)
pp. 594-598.
10.1002/art.40750.
|
|
Bray, TJP;
Singh, S;
Latifoltojar, A;
Rajesparan, K;
Rahman, F;
Narayanan, P;
Naaseri, S;
... Hall-Craggs, MA; + view all
(2017)
Diagnostic utility of whole body Dixon MRI in multiple myeloma: A multi-reader study.
PLoS One
, 12
(7)
, Article e0180562. 10.1371/journal.pone.0180562.
|
|
Bridgewater, J;
Lopes, A;
Beare, S;
Duggan, M;
Lee, D;
Ricamara, M;
McEntee, D;
... Valle, JW; + view all
(2016)
A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study.
BMC Cancer
, 16
(1)
p. 153.
10.1186/s12885-016-2174-8.
|
|
|
Eaton, David J;
Brand, Douglas H;
Hava, Natasha;
Harrison, Mark;
Lopes, Andre;
Manoharan, Prakash;
Radhakrishna, Ganesh;
... Hawkins, Maria A; + view all
(2025)
Radiotherapy plan quality assurance in the ABC-07 trial of stereotactic body radiotherapy (SBRT) for locally advanced biliary tract cancer.
Clinical Oncology
, Article 103993. 10.1016/j.clon.2025.103993.
|
|
|
Ghorashian, S;
Kramer, AM;
Onuoha, S;
Wright, G;
Bartram, J;
Richardson, R;
Albon, SJ;
... Amrolia, PJ; + view all
(2019)
Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR.
Nature Medicine
, 25
pp. 1408-1414.
10.1038/s41591-019-0549-5.
|
|
Glynne-Jones, R;
Adams, R;
Lopes, A;
Meadows, H;
(2017)
Clinical endpoints in trials of chemoradiation for patients with anal cancer.
[Review].
Lancet Oncology
, 18
(4)
E218-E227.
10.1016/S1470-2045(17)30190-0.
|
|
|
Glynne-Jones, R;
Hall, MR;
Lopes, A;
Pearce, S;
Goh, V;
Bosompem, S;
Bridgewater, J;
... Harrison, M; + view all
(2018)
BACCHUS: A randomised non-comparative phase II study of neoadjuvant chemotherapy (NACT) in patients with locally advanced rectal cancer (LARC).
Heliyon
, 4
(9)
, Article e00804. 10.1016/j.heliyon.2018.e00804.
|
|
|
Glynne-Jones, R;
Meadows, HM;
Lopes, A;
Muirhead, R;
Sebag-Montefiore, D;
Adams, R;
ACTII study group;
(2020)
Impact of compliance to chemoradiation on long-term outcomes in squamous cell carcinoma of the anus. Results of a post-hoc analysis from the randomized phase III ACT II trial.
Annals of Oncology
, 31
(10)
pp. 1376-1385.
10.1016/j.annonc.2020.06.012.
|
|
Glynne-Jones, R;
Meadows, HM;
Lopes, A;
Riddle, P;
Duggan, M;
Sebag-Montefiore, D;
McDonald, A;
... Adams, R; + view all
(2020)
A Phase I/II Feasibility Study of Intravenous Cetuximab in Combination with 5 days Weekly Oral Capecitabine and Preoperative Radiotherapy in Rectal Cancer (XERXES).
Archives of Clinical and Biomedical Research
, 4
(4)
pp. 394-412.
10.26502/acbr.50170112.
|
|
|
Gollins, S;
West, N;
Sebag-Montefiore, D;
Myint, AS;
Saunders, M;
Susnerwala, S;
Quirke, P;
... Beare, S; + view all
(2017)
Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations.
British Journal of Cancer
, 117
(9)
pp. 1286-1294.
10.1038/bjc.2017.294.
|
|
|
Hawkins, Maria;
Collins Fekete, Charles-Antoine;
Royle, Gary;
Zhang, Ying;
Lopes, Andre;
Begum, Rubina;
West, Nick P;
... Shen, Zhuoyan; + view all
(2025)
Tumour Cell Density Quantified by Artificial Intelligence Enables Precise Chemo-Radiotherapy Planning for Locally Advanced Rectal Cancer Patients: A Post-hoc Study of the Phase 3 ARISTOTLE Trial.
The Lancet Oncology
(In press).
|
|
Hoskin, PJ;
Hopkins, K;
Misra, V;
Holt, T;
McMenemin, R;
Dubois, D;
McKinna, F;
... Lopes, A; + view all
(2019)
Effect of Single-Fraction vs Multifraction Radiotherapy on Ambulatory Status Among Patients With Spinal Canal Compression From Metastatic Cancer: The SCORAD Randomized Clinical Trial.
JAMA
, 322
(21)
pp. 2084-2094.
10.1001/jama.2019.17913.
|
|
Hough, R;
Lopes, A;
Patrick, P;
Russell, N;
Raj, K;
Tholouli, E;
Snowden, JA;
... Marks, D; + view all
(2022)
Primary graft failure, but not relapse, may be identified by early chimerism following double cord blood unit transplantation.
Blood Advances
, 6
(7)
pp. 2414-2426.
10.1182/bloodadvances.2021005106.
|
|
Lacas, B;
Carmel, A;
Landais, C;
Wong, SJ;
Licitra, L;
Tobias, JS;
Burtness, B;
... MACH-NC Collaborative Group; + view all
(2021)
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group.
Radiotherapy and Oncology
, 156
pp. 281-293.
10.1016/j.radonc.2021.01.013.
|
|
Lamarca, Angela;
Ross, Paul;
Wasan, Harpreet S;
Hubner, Richard A;
McNamara, Mairéad G;
Lopes, Andre;
Palmer, Daniel;
... Bridgewater, John; + view all
(2025)
Advanced Ampullary Cancer: post-hoc analysis of the ABC-01, -02 and -03 clinical trials.
Oncologist
10.1093/oncolo/oyaf399.
(In press).
|
|
|
Lamarca, A;
Ross, P;
Wasan, HS;
Hubner, RA;
McNamara, MG;
Lopes, A;
Manoharan, P;
... Valle, JW; + view all
Advanced intrahepatic cholangiocarcinoma: post-hoc analysis of the ABC-01, -02 and -03 clinical trials.
Journal of the National Cancer Institute
10.1093/jnci/djz071.
(In press).
|
|
|
Latifoltojar, A;
Punwani, S;
Lopes, A;
Humphries, PD;
Klusmann, M;
Menezes, LJ;
Daw, S;
... Taylor, SA; + view all
(2019)
Whole-body MRI for staging and interim response monitoring
in paediatric and adolescent Hodgkin's lymphoma: a comparison
with multi-modality reference standard including 18F-FDG-PET-CT.
European Radiology
, 29
(1)
pp. 202-212.
10.1007/s00330-018-5445-8.
|
|
|
Mandair, D;
Khan, MS;
Lopes, A;
Furtado O'Mahony, L;
Ensell, L;
Lowe, H;
Hartley, JA;
... Meyer, T; + view all
(2021)
Prognostic Threshold for Circulating Tumor Cells in Patients With Pancreatic and Midgut Neuroendocrine Tumors.
Journal of Clinical Endocrinology and Metabolism
, 106
(3)
pp. 872-882.
10.1210/clinem/dgaa822.
|
|
McNamara, MG;
Bridgewater, J;
Lopes, A;
Wasan, H;
Malka, D;
Jensen, LH;
Okusaka, T;
... Valle, JW; + view all
(2017)
Systemic therapy in younger and elderly patients with advanced biliary cancer: sub-analysis of ABC-02 and twelve other prospective trials.
BMC Cancer
, 17
, Article 262. 10.1186/s12885-017-3266-9.
|
|
|
McNamara, MG;
Lopes, A;
Wasan, H;
Malka, D;
Goldstein, D;
Shannon, J;
Okusaka, T;
... Valle, JW; + view all
(2020)
Landmark survival analysis and impact of anatomic origin in prospective clinical trials of biliary tract cancer.
Journal of Hepatology
, 73
(5)
pp. 1109-1117.
10.1016/j.jhep.2020.05.014.
|
|
Meyer, Tim;
Galani, Sevasti;
Lopes, Andre;
Vogel, Arndt;
(2023)
Aetiology of liver disease and response to immune checkpoint inhibitors: an updated meta-analysis confirms benefit in those with non-viral liver disease.
Journal of Hepatology
, 79
(2)
e73-e76.
10.1016/j.jhep.2023.04.012.
|
|
Mossop, H;
Walmsley, Z;
Wilson, N;
Agbeleye, O;
Bardgett, M;
Bevin-Nicholls, A;
Breckons, M;
... Wason, JMS; + view all
(2025)
Practical guidance for conducting high-quality and rapid interim analyses in adaptive clinical trials.
BMC Medicine
, 23
, Article 528. 10.1186/s12916-025-04362-x.
|
 |
|
Petit, C;
Lacas, B;
Pignon, J-P;
Le, QT;
Grégoire, V;
Grau, C;
Hackshaw, A;
... MACH-NC and MARCH Collaborative Groups; + view all
(2021)
Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis.
Lancet Oncology
, 22
(5)
pp. 727-736.
10.1016/S1470-2045(21)00076-0.
|
|
Phillips, EH;
Lannon, M;
Lopes, A;
Chadwick, H;
Jones, G;
Sieniawski, M;
Davies, A;
... Lennard, A; + view all
(2019)
High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study.
[Letter].
Bone Marrow Transplantation
, 54
pp. 465-468.
10.1038/s41409-018-0294-2.
|
|
Townsend, W;
Leong, S;
Hoskin, P;
Diez, P;
Patrick, P;
Linch, D;
Wong, W-L;
... Ardeshna, K; + view all
(2019)
Treatment of classical Hodgkin lymphoma in young adults aged 18-30 years with a modified paediatric Hodgkin lymphoma protocol. Results of a multicentre phase II clinical trial (CRUK/08/012).
British Journal of Haematology
10.1111/bjh.16296.
(In press).
|
|
|
Valle, JW;
Wasan, H;
Lopes, A;
Backen, AC;
Palmer, DH;
Morris, K;
Duggan, M;
... Bridgewater, JA; + view all
(2015)
Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial.
Lancet Oncology
, 16
(8)
pp. 967-978.
10.1016/S1470-2045(15)00139-4.
|
